In lung cancer, not only can BCA inhibit epithelial-mesenchymal transition, but it can also suppress the rate of proliferation of lung cancer cells by activating the Bcl-2 and caspase-3 pathways and by regulating the expression of cell cycle-related proteins [31,41]. Here, BCL2 is linked to lung carcinoma.